CIK 0001567529 · Accelerated filer
KAMADA LTD
Sign in to watch- Ticker
- KMDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 97289406472
- Business address
- 2 HOLTZMAN ST., SCIENCE PARK, REHOVOT, Israel, 7670402
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,650,459
- in 2 filings
Net −$1,650,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-27 | London Amir Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2026-08-27 | Gorelik Boris VP, BD and Strategic Programs | Grant or award · Employee Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2026-08-27 | Payorski Lilach Director | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-08-27 | Payorski Lilach Director | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-08-27 | Reshef Liron VP Human Resources | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2026-08-27 | Reshef Liron VP Human Resources | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2026-08-27 | Goldwasser Karnit Director | Grant or award · Employee Stock Option (right to buy) | +26,500 | 26,500 | ||
| 2026-08-27 | Goldwasser Karnit Director | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-08-27 | Goldwasser Karnit Director | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-08-27 | Beladev Shavit VP Plasma Operations | Grant or award · Employee Stock Option(right to buy) | +15,000 | 15,000 | ||
| 2026-08-27 | Beladev Shavit VP Plasma Operations | Grant or award · Employee Stock Option(right to buy) | +60,000 | 60,000 | ||
| 2026-08-27 | Livneh Nir VP, General Counsel | Grant or award · Employee Stock Option (right to buy) | +29,485 | 29,485 | ||
| 2026-08-27 | Livneh Nir VP, General Counsel | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2026-08-27 | Pinchuk Orit VP Regulatory Affairs | Grant or award · Employee Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2026-08-27 | Pinchuk Orit VP Regulatory Affairs | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2026-08-27 | RECANATI LEON Director | Grant or award · Employee Stock Option (right to buy) | +26,500 | 26,500 | ||
| 2026-08-27 | RECANATI LEON Director | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-08-27 | RECANATI LEON Director | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-08-27 | ORLEV CHAIME Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2026-08-27 | ORLEV CHAIME Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +90,000 | 90,000 |
Page 3 of 16 · 308 trades